Fetal RHD genotyping is a cost-effective option for supporting targeted anti-D prophylaxis in D-negative pregnancies

S. Allard, E. Massey

Research output: Contribution to journalComment/debate (Academic Journal)peer-review

Original languageEnglish
Number of pages1
JournalBJOG: An International Journal of Obstetrics and Gynaecology
Volume125
Issue number11
DOIs
Publication statusPublished - 1 Oct 2018

Cite this